8-K
filed June 24, 2024, 7:59 PM ET
ticker RXRX
CIK 0001601830
other material
confidence high
sentiment positive
materiality 0.75
Recursion gives guidance on seven clinical readouts within ~18 months and Bayer LOWE partnership
RECURSION PHARMACEUTICALS, INC.
- Topline Phase 2 data for REC-994 (CCM) in Sep 2024; prelim Phase 2 data for REC-2282 (NF2) in Q4 2024.
- REC-3964 (C. diff) Phase 2 start Q4 2024; RBM39 IND Q3 2024; Target Epsilon IND early 2025.
- Bayer first beta-user of LOWE platform; joint oncology project towards Lead Series nomination; 25 data packages Q3 2024.
- ADME industrialization ~90x throughput over manual; genome-scale transcriptomics knockout map; 90% success predicting compound failures.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001601830-24-000085
- form_type
- 8-K
- ticker
- RXRX
- cik
- 0001601830
- company_name
- RECURSION PHARMACEUTICALS, INC.
- filed_at
- 2024-06-24T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:19.171300+00:00
- generated_at
- 2026-06-01T02:27:51.251492+00:00
- sec_items
- ["7.01", "9.01"]
- event_type
- other_material
- sentiment
- positive
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001601830-24-000085
- json_url
- https://secwatch.observer/filing/0001601830-24-000085.json
- markdown_url
- https://secwatch.observer/filing/0001601830-24-000085.md
- text_url
- https://secwatch.observer/filing/0001601830-24-000085.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183024000085/0001601830-24-000085-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183024000085/rxrx-20240624.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
KRMN
Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds
Karman Holdings Inc.
June 1, 2026, 5:28 PM ET
other_material
Items 1.01, 7.01, 8.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
TRTX
TRTX posts 1Q26 distributable earnings $0.25/sh, book value $11.06, loan portfolio $4.3B
TPG RE Finance Trust, Inc.
June 1, 2026, 5:23 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
AIB
Blockchain Digital signs 15-yr, 65 MW electric agreement at CLT-01; 25 MW LOIs in pipeline
BlockchAIn Digital Infrastructure, Inc.
June 1, 2026, 4:57 PM ET
other_material
Items 1.01, 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
AII
American Integrity fully places 2026-2027 CAT XOL reinsurance with $2.99B total limit
American Integrity Insurance Group, Inc.
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CSR
Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City
CENTERSPACE
June 1, 2026, 4:30 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
Mid-America Apartments, L.P.
MAA May 2026 blended rents highest in 2 years; repurchased $50M shares
Mid-America Apartments, L.P.
June 1, 2026, 4:20 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
LBTYA
Liberty Global names Stephen van Rooyen as Ziggo Group CEO; plans Amsterdam listing in 2027
Liberty Global Ltd.
June 1, 2026, 4:07 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
IDYA
IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma
IDEAYA Biosciences, Inc.
June 1, 2026, 4:05 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.